The current N1VO34 market cap is 221.71B. The company's latest EPS is DKK 29.7900 and P/E is 3.08.
Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | |
Total Revenue | 126.95B | 140.8B | 176.95B | 232.26B | 290.4B |
Operating Income | 54.28B | 58.62B | 74.62B | 102.66B | 128.32B |
Net Income | 42.14B | 47.76B | 55.53B | 83.68B | 100.99B |
Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | |
Total Assets | 144.92B | 194.51B | 241.26B | 314.49B | 465.8B |
Total Liabilities | 81.6B | 123.76B | 157.77B | 207.93B | 322.31B |
Total Equity | 63.33B | 70.75B | 83.49B | 106.56B | 143.49B |
Market Cap | 221.71B |
Price to Earnings Ratio | 3.08 |
Price to Sales Ratio | 1.07 |
Price to Cash Ratio | 19.9 |
Price to Book Ratio | 2.17 |
Dividend Yield | 0.89% |
Shares Outstanding | 3.39B |
Average Volume (1 week) | 9.53k |
Average Volume (1 Month) | 13.28k |
52 Week Change | -14.83% |
52 Week High | 103.10 |
52 Week Low | 52.50 |
Spread (Intraday) | 3.97 (5.84%) |
Company Name | Novo Nordisk |
Address |
novo alle bagsvaerd DK-2880 |
Website | https://www.novonordisk.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions